Previous work from our group showed that CBD, in MCF-7aro cells, induced cell cycle arrest at the G0/G1 phase, decreased aromatase expression, down-regulated ERα expression, and up-regulated ERβ expression, thus being able to modulate the three main targets responsible for ER+ breast cancer development and progression [38]. The gene discussed is ESR2; the disease is breast carcinoma.